10:35 AM EST - Acerus Pharmaceuticals Corporation : Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus to increase its existing secured loan facility from $37.945 million U.S. to $47.945 million U.S. This increase will be made available to the Company by way of two advances of $5.0 million each on August 5 and 8, under a secured grid promissory note with First Generation. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $3.00.
